Q301--Kidney Disease Gene Panel 1-Year Testing Indy, Cleveland, Cincinnati VA Medical Centers

The Department of Veterans Affairs is seeking information from contractors to provide kidney disease genetic testing services for a period of one year. The services will be provided to patients enrolled in the Richard L. Roudebush VA Medical Center, Louis Stokes Cleveland VA Medical Center, and Cincinnati Department of Veterans Affairs. The contractor will be required to provide specialized kidney gene panel testing, kidney transplant assessment, and molecular residual disease (MRD) surveillance. The contractor must maintain compliance with applicable Federal and State regulations, including CLIA, CAP, and JC accreditations. The contractor must also provide customer service and ensure test sample integrity. • Kidney gene panel testing will include analysis of over 380 genes to diagnose genetic kidney disease. • Kidney transplant assessment will include a non-invasive donor-derived cell-free DNA (dd-cfDNA) blood test. • Molecular Residual Disease (MRD) assay will include a custom designed personalized tumor informed assay for each patient. • The contractor must provide paid shipping and transportation of patient specimens. • The contractor must provide all necessary supplies for biomedical materials to be transported from the VA medical facility to the performing laboratory.